Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Magnetic Resonance Imaging and Bioluminescence Imaging for Evaluating Tumor Burden in Orthotopic Colon Cancer.

Ravoori MK, Margalit O, Singh S, Kim SH, Wei W, Menter DG, DuBois RN, Kundra V.

Sci Rep. 2019 Apr 15;9(1):6100. doi: 10.1038/s41598-019-42230-w.

2.

Back to the Colorectal Cancer Consensus Molecular Subtype Future.

Menter DG, Davis JS, Broom BM, Overman MJ, Morris J, Kopetz S.

Curr Gastroenterol Rep. 2019 Jan 30;21(2):5. doi: 10.1007/s11894-019-0674-9. Review.

PMID:
30701321
3.

Real-Time Interrogation of Aspirin Reactivity, Biochemistry, and Biodistribution by Hyperpolarized Magnetic Resonance Spectroscopy.

Zacharias NM, Ornelas A, Lee J, Hu J, Davis JS, Uddin N, Pudakalakatti S, Menter DG, Karam JA, Wood CG, Hawk ET, Kopetz S, Vilar E, Bhattacharya PK, Millward SW.

Angew Chem Int Ed Engl. 2019 Mar 22;58(13):4179-4183. doi: 10.1002/anie.201812759. Epub 2019 Feb 20.

4.

The COX2 Effector Microsomal PGE2 Synthase 1 is a Regulator of Immunosuppression in Cutaneous Melanoma.

Kim SH, Roszik J, Cho SN, Ogata D, Milton DR, Peng W, Menter DG, Ekmekcioglu S, Grimm EA.

Clin Cancer Res. 2019 Mar 1;25(5):1650-1663. doi: 10.1158/1078-0432.CCR-18-1163. Epub 2018 Dec 11.

PMID:
30538110
5.

Bioactive lipid metabolism in platelet "first responder" and cancer biology.

Kanikarla-Marie P, Kopetz S, Hawk ET, Millward SW, Sood AK, Gresele P, Overman M, Honn K, Menter DG.

Cancer Metastasis Rev. 2018 Sep;37(2-3):439-454. doi: 10.1007/s10555-018-9755-8. Review.

PMID:
30112590
6.

Platelet Metabolism and Other Targeted Drugs; Potential Impact on Immunotherapy.

Kanikarla-Marie P, Lam M, Sorokin AV, Overman MJ, Kopetz S, Menter DG.

Front Oncol. 2018 Apr 20;8:107. doi: 10.3389/fonc.2018.00107. eCollection 2018. Review.

7.

The Platelet Lifeline to Cancer: Challenges and Opportunities.

Haemmerle M, Stone RL, Menter DG, Afshar-Kharghan V, Sood AK.

Cancer Cell. 2018 Jun 11;33(6):965-983. doi: 10.1016/j.ccell.2018.03.002. Epub 2018 Apr 12. Review.

8.

Arginine methylation of EGFR: a new biomarker for predicting resistance to anti-EGFR treatment.

Korphaisarn K, Chou CK, Xia WY, Clarke CN, Katkhuda R, Davis JS, Raghav KP, Liao HW, Wu JY, Menter DG, Maru DM, Hung MC, Kopetz S.

Am J Cancer Res. 2017 Dec 1;7(12):2587-2599. eCollection 2017.

9.

Classifying Colorectal Cancer by Tumor Location Rather than Sidedness Highlights a Continuum in Mutation Profiles and Consensus Molecular Subtypes.

Loree JM, Pereira AAL, Lam M, Willauer AN, Raghav K, Dasari A, Morris VK, Advani S, Menter DG, Eng C, Shaw K, Broaddus R, Routbort MJ, Liu Y, Morris JS, Luthra R, Meric-Bernstam F, Overman MJ, Maru D, Kopetz S.

Clin Cancer Res. 2018 Mar 1;24(5):1062-1072. doi: 10.1158/1078-0432.CCR-17-2484. Epub 2017 Nov 27.

10.

Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention.

Ornelas A, Zacharias-Millward N, Menter DG, Davis JS, Lichtenberger L, Hawke D, Hawk E, Vilar E, Bhattacharya P, Millward S.

Cancer Metastasis Rev. 2017 Jun;36(2):289-303. doi: 10.1007/s10555-017-9675-z. Review.

11.

Platelet "first responders" in wound response, cancer, and metastasis.

Menter DG, Kopetz S, Hawk E, Sood AK, Loree JM, Gresele P, Honn KV.

Cancer Metastasis Rev. 2017 Jun;36(2):199-213. doi: 10.1007/s10555-017-9682-0. Review.

12.

The potential role of platelets in the consensus molecular subtypes of colorectal cancer.

Lam M, Roszik J, Kanikarla-Marie P, Davis JS, Morris J, Kopetz S, Menter DG.

Cancer Metastasis Rev. 2017 Jun;36(2):273-288. doi: 10.1007/s10555-017-9678-9. Review.

PMID:
28681242
13.

Platelets, circulating tumor cells, and the circulome.

Kanikarla-Marie P, Lam M, Menter DG, Kopetz S.

Cancer Metastasis Rev. 2017 Jun;36(2):235-248. doi: 10.1007/s10555-017-9681-1. Review.

PMID:
28667367
14.

The somatic mutation landscape of premalignant colorectal adenoma.

Lin SH, Raju GS, Huff C, Ye Y, Gu J, Chen JS, Hildebrandt MAT, Liang H, Menter DG, Morris J, Hawk E, Stroehlein JR, Futreal A, Kopetz S, Mishra L, Wu X.

Gut. 2018 Jul;67(7):1299-1305. doi: 10.1136/gutjnl-2016-313573. Epub 2017 Jun 12.

15.

Modeling of Patient-Derived Xenografts in Colorectal Cancer.

Katsiampoura A, Raghav K, Jiang ZQ, Menter DG, Varkaris A, Morelli MP, Manuel S, Wu J, Sorokin AV, Rizi BS, Bristow C, Tian F, Airhart S, Cheng M, Broom BM, Morris J, Overman MJ, Powis G, Kopetz S.

Mol Cancer Ther. 2017 Jul;16(7):1435-1442. doi: 10.1158/1535-7163.MCT-16-0721. Epub 2017 May 3.

16.

Endothelial cell malignancies: new insights from the laboratory and clinic.

Wagner MJ, Ravi V, Menter DG, Sood AK.

NPJ Precis Oncol. 2017 Apr 20;1(1):11. doi: 10.1038/s41698-017-0013-2. eCollection 2017.

17.

Dual Inhibition of EGFR and c-Src by Cetuximab and Dasatinib Combined with FOLFOX Chemotherapy in Patients with Metastatic Colorectal Cancer.

Parseghian CM, Parikh NU, Wu JY, Jiang ZQ, Henderson L, Tian F, Pastor B, Ychou M, Raghav K, Dasari A, Fogelman DR, Katsiampoura AD, Menter DG, Wolff RA, Eng C, Overman MJ, Thierry AR, Gallick GE, Kopetz S.

Clin Cancer Res. 2017 Aug 1;23(15):4146-4154. doi: 10.1158/1078-0432.CCR-16-3138. Epub 2017 Mar 9.

18.

Right Versus Left Colon Cancer Biology: Integrating the Consensus Molecular Subtypes.

Lee MS, Menter DG, Kopetz S.

J Natl Compr Canc Netw. 2017 Mar;15(3):411-419. Review.

PMID:
28275039
19.

Developing hyperpolarized silicon particles for in vivo MRI targeting of ovarian cancer.

Whiting N, Hu J, Zacharias NM, Lokesh GL, Volk DE, Menter DG, Rupaimoole R, Previs R, Sood AK, Bhattacharya P.

J Med Imaging (Bellingham). 2016 Jul;3(3):036001. doi: 10.1117/1.JMI.3.3.036001. Epub 2016 Aug 10.

20.

Mechanisms of nonsteroidal anti-inflammatory drugs in cancer prevention.

Umar A, Steele VE, Menter DG, Hawk ET.

Semin Oncol. 2016 Feb;43(1):65-77. doi: 10.1053/j.seminoncol.2015.09.010. Epub 2015 Sep 10. Review.

PMID:
26970125
21.

Microsomal PGE2 synthase-1 regulates melanoma cell survival and associates with melanoma disease progression.

Kim SH, Hashimoto Y, Cho SN, Roszik J, Milton DR, Dal F, Kim SF, Menter DG, Yang P, Ekmekcioglu S, Grimm EA.

Pigment Cell Melanoma Res. 2016 May;29(3):297-308. doi: 10.1111/pcmr.12455. Epub 2016 Mar 15.

22.

Real-Time MRI-Guided Catheter Tracking Using Hyperpolarized Silicon Particles.

Whiting N, Hu J, Shah JV, Cassidy MC, Cressman E, Millward NZ, Menter DG, Marcus CM, Bhattacharya PK.

Sci Rep. 2015 Aug 4;5:12842. doi: 10.1038/srep12842.

23.

Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer.

Chen ZY, Raghav K, Lieu CH, Jiang ZQ, Eng C, Vauthey JN, Chang GJ, Qiao W, Morris J, Hong D, Hoff P, Tran H, Menter DG, Heymach J, Overman M, Kopetz S.

Br J Cancer. 2015 Mar 17;112(6):1088-97. doi: 10.1038/bjc.2015.61.

24.

Convergence of nanotechnology and cancer prevention: are we there yet?

Menter DG, Patterson SL, Logsdon CD, Kopetz S, Sood AK, Hawk ET.

Cancer Prev Res (Phila). 2014 Oct;7(10):973-92. doi: 10.1158/1940-6207.CAPR-14-0079. Epub 2014 Jul 24. Review.

25.

Platelets and cancer: a casual or causal relationship: revisited.

Menter DG, Tucker SC, Kopetz S, Sood AK, Crissman JD, Honn KV.

Cancer Metastasis Rev. 2014 Mar;33(1):231-69. doi: 10.1007/s10555-014-9498-0. Review.

26.

Prostaglandin E2 regulates pancreatic stellate cell activity via the EP4 receptor.

Charo C, Holla V, Arumugam T, Hwang R, Yang P, Dubois RN, Menter DG, Logsdon CD, Ramachandran V.

Pancreas. 2013 Apr;42(3):467-74. doi: 10.1097/MPA.0b013e318264d0f8.

27.

Prostaglandins in cancer cell adhesion, migration, and invasion.

Menter DG, Dubois RN.

Int J Cell Biol. 2012;2012:723419. doi: 10.1155/2012/723419. Epub 2012 Feb 29.

28.

Differential effects of pravastatin and simvastatin on the growth of tumor cells from different organ sites.

Menter DG, Ramsauer VP, Harirforoosh S, Chakraborty K, Yang P, Hsi L, Newman RA, Krishnan K.

PLoS One. 2011;6(12):e28813. doi: 10.1371/journal.pone.0028813. Epub 2011 Dec 22.

29.

Nuclear orphan receptor NR4A2 modulates fatty acid oxidation pathways in colorectal cancer.

Holla VR, Wu H, Shi Q, Menter DG, DuBois RN.

J Biol Chem. 2011 Aug 26;286(34):30003-9. doi: 10.1074/jbc.M110.184697. Epub 2011 Jul 10.

30.

γ-Tocotrienol induces growth arrest through a novel pathway with TGFβ2 in prostate cancer.

Campbell SE, Rudder B, Phillips RB, Whaley SG, Stimmel JB, Leesnitzer LM, Lightner J, Dessus-Babus S, Duffourc M, Stone WL, Menter DG, Newman RA, Yang P, Aggarwal BB, Krishnan K.

Free Radic Biol Med. 2011 May 15;50(10):1344-54. doi: 10.1016/j.freeradbiomed.2011.02.007. Epub 2011 Feb 16.

PMID:
21335085
31.

Human enhancer of filamentation 1 Is a mediator of hypoxia-inducible factor-1alpha-mediated migration in colorectal carcinoma cells.

Kim SH, Xia D, Kim SW, Holla V, Menter DG, Dubois RN.

Cancer Res. 2010 May 15;70(10):4054-63. doi: 10.1158/0008-5472.CAN-09-2110. Epub 2010 May 4.

32.

Cyclooxygenase-2 and cancer treatment: understanding the risk should be worth the reward.

Menter DG, Schilsky RL, DuBois RN.

Clin Cancer Res. 2010 Mar 1;16(5):1384-90. doi: 10.1158/1078-0432.CCR-09-0788. Epub 2010 Feb 23. Review.

33.

HEF1 is a crucial mediator of the proliferative effects of prostaglandin E(2) on colon cancer cells.

Xia D, Holla VR, Wang D, Menter DG, DuBois RN.

Cancer Res. 2010 Jan 15;70(2):824-31. doi: 10.1158/0008-5472.CAN-09-2105. Epub 2010 Jan 12.

34.

Oleandrin-mediated inhibition of human tumor cell proliferation: importance of Na,K-ATPase alpha subunits as drug targets.

Yang P, Menter DG, Cartwright C, Chan D, Dixon S, Suraokar M, Mendoza G, Llansa N, Newman RA.

Mol Cancer Ther. 2009 Aug;8(8):2319-28. doi: 10.1158/1535-7163.MCT-08-1085. Epub 2009 Aug 11.

35.

Activator protein-1 has an essential role in pancreatic cancer cells and is regulated by a novel Akt-mediated mechanism.

Shin S, Asano T, Yao Y, Zhang R, Claret FX, Korc M, Sabapathy K, Menter DG, Abbruzzese JL, Reddy SAG.

Mol Cancer Res. 2009 May;7(5):745-754. doi: 10.1158/1541-7786.MCR-08-0462. Epub 2009 May 12.

36.

Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer.

Tsavachidou D, McDonnell TJ, Wen S, Wang X, Vakar-Lopez F, Pisters LL, Pettaway CA, Wood CG, Do KA, Thall PF, Stephens C, Efstathiou E, Taylor R, Menter DG, Troncoso P, Lippman SM, Logothetis CJ, Kim J.

J Natl Cancer Inst. 2009 Mar 4;101(5):306-20. doi: 10.1093/jnci/djn512. Epub 2009 Feb 24.

37.

Survivin expression in normal human bronchial epithelial cells: an early and critical step in tumorigenesis induced by tobacco exposure.

Jin Q, Menter DG, Mao L, Hong WK, Lee HY.

Carcinogenesis. 2008 Aug;29(8):1614-22. doi: 10.1093/carcin/bgm234. Epub 2008 Jul 16.

38.

Establishment of three-dimensional cultures of human pancreatic duct epithelial cells.

Gutierrez-Barrera AM, Menter DG, Abbruzzese JL, Reddy SA.

Biochem Biophys Res Commun. 2007 Jul 6;358(3):698-703. Epub 2007 May 4.

39.

15-Lipoxygenase-2 gene regulation by its product 15-(S)-hydroxyeicosatetraenoic acid through a negative feedback mechanism that involves peroxisome proliferator-activated receptor gamma.

Subbarayan V, Krieg P, Hsi LC, Kim J, Yang P, Sabichi AL, Llansa N, Mendoza G, Logothetis CJ, Newman RA, Lippman SM, Menter DG.

Oncogene. 2006 Sep 28;25(44):6015-25. Epub 2006 May 8.

PMID:
16682954
40.

Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group Study.

Sabichi AL, Lee JJ, Taylor RJ, Thompson IM, Miles BJ, Tangen CM, Minasian LM, Pisters LL, Caton JR, Basler JW, Lerner SP, Menter DG, Marshall JR, Crawford ED, Lippman SM.

Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2178-84.

41.

Suppression of prostate tumor cell growth by stromal cell prostaglandin D synthase-derived products.

Kim J, Yang P, Suraokar M, Sabichi AL, Llansa ND, Mendoza G, Subbarayan V, Logothetis CJ, Newman RA, Lippman SM, Menter DG.

Cancer Res. 2005 Jul 15;65(14):6189-98.

42.

Inverse relationship between 15-lipoxygenase-2 and PPAR-gamma gene expression in normal epithelia compared with tumor epithelia.

Subbarayan V, Xu XC, Kim J, Yang P, Hoque A, Sabichi AL, Llansa N, Mendoza G, Logothetis CJ, Newman RA, Lippman SM, Menter DG.

Neoplasia. 2005 Mar;7(3):280-93.

43.

Differential peroxisome proliferator-activated receptor-gamma isoform expression and agonist effects in normal and malignant prostate cells.

Subbarayan V, Sabichi AL, Kim J, Llansa N, Logothetis CJ, Lippman SM, Menter DG.

Cancer Epidemiol Biomarkers Prev. 2004 Nov;13(11 Pt 1):1710-6.

44.

Peroxisome proliferator-activated receptor-gamma suppresses cyclooxygenase-2 expression in human prostate cells.

Sabichi AL, Subbarayan V, Llansa N, Lippman SM, Menter DG.

Cancer Epidemiol Biomarkers Prev. 2004 Nov;13(11 Pt 1):1704-9.

45.

Formation and antiproliferative effect of prostaglandin E(3) from eicosapentaenoic acid in human lung cancer cells.

Yang P, Chan D, Felix E, Cartwright C, Menter DG, Madden T, Klein RD, Fischer SM, Newman RA.

J Lipid Res. 2004 Jun;45(6):1030-9. Epub 2004 Mar 1.

46.

Glycogen synthase kinase-3 beta is involved in the phosphorylation and suppression of androgen receptor activity.

Salas TR, Kim J, Vakar-Lopez F, Sabichi AL, Troncoso P, Jenster G, Kikuchi A, Chen SY, Shemshedini L, Suraokar M, Logothetis CJ, DiGiovanni J, Lippman SM, Menter DG.

J Biol Chem. 2004 Apr 30;279(18):19191-200. Epub 2004 Feb 24.

47.

Alleviating the suppression of glycogen synthase kinase-3beta by Akt leads to the phosphorylation of cAMP-response element-binding protein and its transactivation in intact cell nuclei.

Salas TR, Reddy SA, Clifford JL, Davis RJ, Kikuchi A, Lippman SM, Menter DG.

J Biol Chem. 2003 Oct 17;278(42):41338-46. Epub 2003 Aug 4.

48.

Cyclooxygenase 2 selective inhibitors in cancer treatment and prevention.

Menter DG.

Expert Opin Investig Drugs. 2002 Dec;11(12):1749-64. Review.

PMID:
12457435
49.

Her-2/neu gene amplification in ductal carcinoma in situ of the breast.

Hoque A, Sneige N, Sahin AA, Menter DG, Bacus JW, Hortobagyi GN, Lippman SM.

Cancer Epidemiol Biomarkers Prev. 2002 Jun;11(6):587-90.

50.

Computerized image analysis of Ki-67 in ductal breast carcinoma in situ.

Menter DG, Hoque A, Motiwala N, Sahin AA, Sneige N, Lieberman R, Lippman SM.

Anal Quant Cytol Histol. 2001 Jun;23(3):218-28.

PMID:
11444192

Supplemental Content

Loading ...
Support Center